Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

The Expanding Role of the Pharmacist in HIV Prevention: What Do You Know About PrEP?

Access Activity

Overview / Abstract:

The most recent estimates from the Centers for Disease Control and Prevention (CDC) state that approximately 37,000 people in the United States become infected with HIV each year.1 To reduce the number of new infections, health care providers should be prepared to discuss the potential benefits of preexposure prophylaxis (PrEP) with adults who are at particularly high risk for acquiring HIV.2 The United States Public Health Service (USPHS) and the CDC have published clinical practice guidelines on identifying candidates and prescribing medication approved by the US Food and Drug Administration (FDA) for HIV PrEP.3 During this Interactive Exchange™ program, expert faculty will review these guidelines with a focus on how pharmacists can facilitate patient engagement and retention in HIV-prevention services.4 Key topics will include recommendations on universal HIV testing, cohorts at substantial risk for HIV acquisition, criteria for PrEP eligibility, and practical approaches to monitoring PrEP outcomes and adherence.1 Faculty will also discuss the growing evidence pool supporting pharmacy-based programs to highlight opportunities for program attendees to play increasingly central roles in the prevention of new HIV infections.5

References:
1. CDC. CDC fact sheet: HIV incidence: estimated annual infections in the U.S., 2008-2014. Overall and by transmission route. . Accessed October 31, 2017.
2. Truvada (emtricitabine/tenofovir disoproxil fumarate) [prescribing information]. Initial US approval 2004. Foster City, CA: Gilead Sciences, Inc; 2017.
3. CDC. USPHS Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014. https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed October 31, 2017.
4. CDC. Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV. https://www.cdc.gov/hiv/risk/estimates/preventionstrategies.html. Updated March 2017. Accessed October 31, 2017.
5. CDC. Innovative CDC effort expands HIV testing into pharmacies. http://www.cdc.gov/nchhstp/newsroom/2012/nhtdpressrelease2012.html. Published June 2012. Accessed October 31, 2017.

Expiration

Mar 05, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

1.0

Accreditation

ACPE, ANCC, ACCME, CE

Presenters / Authors / Faculty

Richard A. Elion, MD; James D. Scott, BS, MEd, PharmD; Elyse Tung, PharmD, BCACP

Sponsors / Supporters / Grant Providers

This activity has been supported by an independent educational grant from Gilead Sciences, Inc and jointly provided by Postgraduate Institute for Medicine and Integritas Communications.

Keywords / Search Terms

Integritas Communications, ACPE, ANCC, ACCME, credit, Pharmacist, HIV, prevention, PrEP, Free CE, Free CME, CME, CE, human immunodeficiency virus, Pre-exposure prophylaxis, Continuing Medical Education, Continuing Education, video, webcast, Elion, Scott, Tung, Centers for Disease Control and Prevention, CDC, United States Public Health Service, USPHS, US Food and Drug Administration, FDA, Interactive Exchange

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map